The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses

Cell Rep. 2022 Jul 26;40(4):111138. doi: 10.1016/j.celrep.2022.111138. Epub 2022 Jul 8.

Abstract

COVID-19 vaccines elicit humoral and cellular immune responses. Durable maintenance of vaccine-induced immunity is required for long-term protection of the host. Here, we examine activation and differentiation of vaccine-induced CD8+ T cells using MHC class I (MHC-I) multimers and correlations between early differentiation and the durability of CD8+ T cell responses among healthcare workers immunized with two doses of BNT162b2. The frequency of MHC-I multimer+ cells is robustly increased by BNT162b2 but decreases 6 months post-second vaccination to 2.4%-65.6% (23.0% on average) of the peak. MHC-I multimer+ cells dominantly exhibit phenotypes of activated effector cells 1-2 weeks post-second vaccination and gradually acquire phenotypes of long-term memory cells, including stem cell-like memory T (TSCM) cells. Importantly, the frequency of TSCM cells 1-2 weeks post-second vaccination significantly correlates with the 6-month durability of CD8+ T cells, indicating that early generation of TSCM cells determines the longevity of vaccine-induced memory CD8+ T cell responses.

Keywords: CD8(+) T cell; COVID-19; CP: Immunology; MHC class I multimer; SARS-CoV-2; memory cell; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine
  • CD8-Positive T-Lymphocytes*
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Stem Cells
  • Vaccination

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • BNT162 Vaccine